Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Graninger

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Scientific Reports|February 8, 2025
Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrationsVerena Vogi, David Haschka, Lukas Forer, et al.
Frontiers in Immunology|April 7, 2025
Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunityDavid M Florian, Michael Bauer, Amelie Popovitsch, et al.
Journal of Clinical Microbiology|February 19, 2021
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other ImmunoassaysGeorg Semmler, Marianna Theresia Traugott, Marianne Graninger, et al.
Frontiers in Immunology|August 5, 2022
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 InfectionsIris Medits, David N Springer, Marianne Graninger, et al.
Annals of the Rheumatic Diseases|July 21, 2021
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunityDaniel Mrak, Selma Tobudic, Maximilian Koblischke, et al.
Nature Communications|July 14, 2025
Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1<sub>381-452</sub>-specific antibody titersHannes Vietzen, Laura M Kühner, Sarah M Berger, et al.
Microbiology Spectrum|August 25, 2022
Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron VariantDavid Niklas Springer, Thomas Perkmann, Claudia Maria Jani, et al.
Annals of Neurology|January 24, 2022
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic PatientsBarbara Kornek, Fritz Leutmezer, Paulus S Rommer, et al.
JAMA Neurology|March 9, 2026
Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory DiseasesHannes Vietzen, Laura M Kühner, Sarah M Berger, et al.
Science Immunology|March 5, 2021
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8<sup>+</sup> T cell responsesBenedikt Agerer, Maximilian Koblischke, Venugopal Gudipati, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Scientific Reports|February 8, 2025
Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrationsVerena Vogi, David Haschka, Lukas Forer, et al.
Frontiers in Immunology|April 7, 2025
Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunityDavid M Florian, Michael Bauer, Amelie Popovitsch, et al.
Journal of Clinical Microbiology|February 19, 2021
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other ImmunoassaysGeorg Semmler, Marianna Theresia Traugott, Marianne Graninger, et al.
Frontiers in Immunology|August 5, 2022
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 InfectionsIris Medits, David N Springer, Marianne Graninger, et al.
Annals of the Rheumatic Diseases|July 21, 2021
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunityDaniel Mrak, Selma Tobudic, Maximilian Koblischke, et al.
Nature Communications|July 14, 2025
Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1<sub>381-452</sub>-specific antibody titersHannes Vietzen, Laura M Kühner, Sarah M Berger, et al.
Microbiology Spectrum|August 25, 2022
Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron VariantDavid Niklas Springer, Thomas Perkmann, Claudia Maria Jani, et al.
Annals of Neurology|January 24, 2022
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic PatientsBarbara Kornek, Fritz Leutmezer, Paulus S Rommer, et al.
JAMA Neurology|March 9, 2026
Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory DiseasesHannes Vietzen, Laura M Kühner, Sarah M Berger, et al.
Science Immunology|March 5, 2021
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8<sup>+</sup> T cell responsesBenedikt Agerer, Maximilian Koblischke, Venugopal Gudipati, et al.
Pageof 2